Ameritas Investment Partners, Inc. Landos Biopharma, Inc. Transaction History

Ameritas Investment Partners, Inc.

  • $2.86 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.6 - $1.5 $309 - $772
-515 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$9.47 - $16.26 $4,877 - $8,373
515 New
515 $5,000

Others Institutions Holding LABP

# of Institutions
1
Shares Held
12
Call Options Held
0
Put Options Held
0
View Full List

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email